<scp>HLA‐DRB1</scp>*13:01 allele in the genetic susceptibility to colorectal carcinoma
Anna Aureli(Istituto di Farmacologia Traslazionale), Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Roberto Arriga(University of Rome Tor Vergata), A. Canossi(Istituto di Farmacologia Traslazionale), Sara Caratelli(National Academies of Sciences, Engineering, and Medicine), Tiziana Del Beato(Istituto di Farmacologia Traslazionale), Davide Lauro(University of Rome Tor Vergata), Giulia Lanzilli(Istituto di Farmacologia Traslazionale), Augusto Orlandi(University of Rome Tor Vergata), Oreste Claudio Buonomo(University of Basilicata), Pierpaolo Sileri(Vita-Salute San Raffaele University), F. Papola(San Salvatore Hospital), Luana Franceschilli(University of Rome Tor Vergata), Andrea Coppola(University of Rome Tor Vergata), Flavio De Sanctis(University of Rome Tor Vergata), P Rossi(University of Rome Tor Vergata)
Cited by 20
Related Papers
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
|Journal of Clinical Medicine|2020|252
NK cells and T cells cooperate during the clinical course of colorectal cancer
|OncoImmunology|2014|153